| 18/12/2014 |
Cleansing Notice and Appendix 3B |
| 15/12/2014 |
Cellmid Capital Raising |
| 15/12/2014 |
Key Midkine Antibody Patent Granted |
| 11/12/2014 |
Trading Halt |
| 17/11/2014 |
Cellmid Signs Agreement with Zoetis |
| 29/10/2014 |
Appendix 4C – quarterly |
| 10/10/2014 |
AGM Presentation by CEO |
| 10/10/2014 |
Results of Meeting |
| 16/09/2014 |
Cellmid 2014 Annual Report to Shareholders |
| 29/08/2014 |
Appendix 4E and Preliminary Final Report |
| 18/08/2014 |
Cellmid News |
| 29/07/2014 |
Appendix 4C – quarterly |
| 16/07/2014 |
Cellmid Granted UK Patent for Use of Midkine for Hair Growth |
| 15/07/2014 |
Landmark Study – FGF5 Critical Regulator of Human Hair Growth |
| 20/06/2014 |
Quest Diagnostic License Update |
| 19/06/2014 |
Manufacturing Partner Appointed by Cellmid |
| 02/06/2014 |
Change of Director’s Interest Notice – Graeme Kaufman |
| 20/05/2014 |
Notice of ceasing to be a substantial holder |
| 07/05/2014 |
Key Milestone Completed: Cellmid Lead Antibody Selected for Clinical Trials |
| 30/04/2014 |
Significant New Findings Presented at 3rd Midkine Symposium in Kyoto |
| 28/04/2014 |
Appendix 4C – quarterly |
| 22/04/2014 |
Release of Shares from Voluntary Escrow |
| 15/04/2014 |
Cellmid Signs Mk Tribody Collaboration Agreement |
| 31/03/2014 |
Presentation to the Market |
| 24/03/2014 |
Cellmid News |
| 27/02/2014 |
Appendix 4D and Half Year Report |
| 17/02/2014 |
Cleansing Notice and Appendix 3B |
| 10/02/2014 |
USA RNA/DNA Patent for Surgical Adhesion Allowed |
| 29/01/2014 |
Chinese Distribution Agreement Signed for Hair Loss Products |
| 28/01/2014 |
Appendix 4C – quarterly |
| 06/01/2014 |
Change of Director’s Interest Notice – Maria Halasz |
